Phase Forward Incorporated (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, announced today that it will be hosting an analyst day on Tuesday, June 23, 2009, in conjunction with the Drug Information Association’s Annual Meeting in San Diego, CA. The management team will discuss the Company’s market opportunity, product strategy, InForm™ GTM release, recent acquisition of Waban Software and financial highlights.
The Phase Forward presentation will begin at 9:00 a.m. Pacific Time and is expected to last approximately two hours. Phase Forward executives presenting at the event will include:
- Bob Weiler, Chairman, President and Chief Executive Officer
- Martin Young, Vice President, Corporate Development and Marketing
- Steve Rosenberg, Senior Vice President, R&D and Services
- Pankaj Tyagi, Vice President, Waban Development
- Chris Menard, Senior Vice President, Chief Financial Officer
The presentation will be webcast live and will be available by visiting the Investor Relations section of the website at www.phaseforward.com. The webcast will be archived on the Company’s website for 30 days after the presentation ends.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 290 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
Contacts:
Public Relations
CHEN PR, Inc.
Barbara Heffner, 781-672-3112
bheffner@chenpr.com
or
Investor
Relations
Integrated Corporate Relations
Timothy Dolan,
617-956-6727
tdolan@icrinc.com
